Simon Gompertz

Birmingham, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Bisoprolol for patients with chronic obstructive pulmonary disease at high risk of exacerbation: the BICS RCT.

Bisoprolol for patients with chronic obstructive pulmonary disease at high risk of exacerbation: the BICS RCT.

Journal: Health technology assessment (Winchester, England)
Published: May 19, 2025

Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical Trial.

Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical Trial.

Journal: JAMA
Published: May 19, 2024

Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS).

Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS).

Journal: Trials
Published: January 31, 2022

Increase in recruitment upon integration of trial into a clinical care pathway: an observational study.

Increase in recruitment upon integration of trial into a clinical care pathway: an observational study.

Journal: BMJ open respiratory research
Published: April 21, 2021

Correction to: Resolution of Persistent COVID-19 After Convalescent Plasma in a Patient with B Cell Aplasia.

Correction to: Resolution of Persistent COVID-19 After Convalescent Plasma in a Patient with B Cell Aplasia.

Journal: Journal of clinical immunology
Published: March 31, 2021

Resolution of Persistent COVID-19 After Convalescent Plasma in a Patient with B Cell Aplasia.

Resolution of Persistent COVID-19 After Convalescent Plasma in a Patient with B Cell Aplasia.

Journal: Journal of clinical immunology
Published: December 23, 2020

Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.

Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.

Journal: Health technology assessment (Winchester, England)
Published: July 26, 2019

Effect of Theophylline as Adjunct to Inhaled Corticosteroids on Exacerbations in Patients With COPD: A Randomized Clinical Trial.

Effect of Theophylline as Adjunct to Inhaled Corticosteroids on Exacerbations in Patients With COPD: A Randomized Clinical Trial.

Journal: JAMA
Published: October 17, 2018

Chinese green tea and acute hepatitis: a rare yet recurring theme.

Chinese green tea and acute hepatitis: a rare yet recurring theme.

Journal: BMJ case reports
Published: September 25, 2015

Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial.

Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial.

Journal: Trials
Published: August 27, 2014

A ''not so superficial" skin infection in a patient with diabetes.

A ''not so superficial" skin infection in a patient with diabetes.

Journal: BMJ case reports
Published: November 01, 2012
Showing 1-11 of 11

Last Updated: 09/26/2026